文献速递产科

宫内装置在产后出血管理中的应用

Intrauterine devices in the management of postpartum hemorrhage.
PubMed 文献 · Am J Obstet Gynecol · 2023-08-30

产后出血是常见的产科并发症和孕产妇死亡原因,多数死亡可预防。宫内填塞、球囊填塞和真空装置是难治性出血的处理选择;球囊装置近期Meta分析止血有效率85.9%,Jada真空装置单臂试验止血成功率94%,上市后登记研究阴道分娩95.8%、剖宫产88.2%。世界卫生组织建议球囊填塞仅限有监测和升级救治条件的机构使用。

要点

  • 球囊填塞装置近期Meta分析止血有效率为85.9%,子宫收缩乏力时成功率最高。
  • 世界卫生组织建议临时自制球囊填塞仅限有监测和升级救治条件的机构使用。
  • Jada真空装置单臂试验止血成功率94%,上市后登记研究阴道分娩95.8%、剖宫产88.2%。

核心结论

  • 宫内装置是处理难治性产后出血的一种选择,近期装置种类快速增加。
  • 需要进一步开展装置间头对头疗效比较,并结合装置定价与整体医疗资源利用评估成本。

研究设计与样本

  • 本文为综述,汇总宫内填塞、球囊填塞和宫内真空装置用于产后出血管理的文献。

主要发现

  • 历史队列记录宫内填塞成功率高;壳聚糖覆盖纱布等现代填塞材料在小规模试验中成功率与子宫球囊填塞相当。
  • 近期Meta分析引用球囊装置止血有效率为85.9%,子宫收缩乏力时成功率最高。
  • 近期随机试验显示低资源环境下使用临时自制球囊填塞可能存在伤害。
  • Jada装置在初始单臂试验中94%病例成功控制出血;上市后登记研究描述阴道分娩后治疗成功率95.8%、剖宫产分娩后88.2%。
  • 临时自制真空装置的成功使用已在多项研究中描述,包括经Levin管行吸引管子宫填塞及使用改良Bakri球囊。

关键数值与推荐

  • 世界卫生组织推荐球囊填塞的使用限制在有监测条件且能够升级救治的机构。
  • 球囊装置止血有效率85.9%(近期Meta分析)。
  • Jada装置初始单臂试验止血成功率94%;上市后登记研究阴道分娩治疗成功率95.8%、剖宫产分娩88.2%。

临床怎么用

  • 宫内填塞、球囊填塞和真空装置可用于难治性产后出血的止血处理。
  • 世界卫生组织推荐球囊填塞仅限有监测和升级救治条件的机构使用。

局限性

  • 近期随机试验显示低资源环境下使用临时自制球囊填塞可能存在伤害。
  • 需要进一步开展装置间头对头疗效比较,并结合装置定价与整体医疗资源利用评估成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obstetrical hemorrhage is a relatively frequent obstetrical complication and a common cause of maternal morbidity and mortality worldwide. The majority of maternal deaths attributable to hemorrhage are preventable, thus, developing rapid and effective means of treating postpartum hemorrhage is of critical public health importance. Intrauterine devices are one option for managing refractory hemorrhage, with rapid expansion of available devices in recent years. Intrauterine packing was historically used for this purpose, with historical cohorts documenting high rates of success. Modern packing materials, including chitosan-covered gauze, have recently been explored with success rates comparable to uterine balloon tamponade in small trials. There are a variety of balloon tamponade devices, both commercial and improvised, available for use. Efficacy of 85.9% was cited in a recent meta-analysis in resolution of hemorrhage with the use of uterine balloon devices, with greatest success in the setting of atony. However, recent randomized trials have demonstrated potential harm associated with improvised balloon tamponade use In low resource settings and the World Health Organization recommends use be restricted to settings where monitoring is available and care escalation is possible. Recently, intrauterine vacuum devices have been introduced, which offer a new mechanism for achieving hemorrhage control by mechanically restoring uterine tone via vacuum suction. The Jada device, which is is FDA-cleared and commercially available in the US, found successful bleeding control in 94% of cases in an initial single-arm trial, with recent post marketing registry study described treatment success following hemorrhage in 95.8% of vaginal and 88.2% of cesarean births. Successful use of improvised vacuum devices has been described in several studies, including suction tube uterine tamponade via Levin tubing, and use of a modified Bakri balloon. Further research is needed with head-to-head comparisons of efficacy of devices and assessment of cost within the context of both device pricing and overall healthcare resource utilization.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Overton E, D'Alton M, Goffman D, et al. Intrauterine devices in the management of postpartum hemorrhage. Am J Obstet Gynecol. 2023. PMID: 37690862. doi:10.1016/j.ajog.2023.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。